{
  "docId": "019de073-a7b5-7720-904b-d55cb9d2acd2",
  "docSlug": "ff09795c4205ae982e453519f0f2447b",
  "documentTitle": "Bionomics | Investor Presentation Deck | 59 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 46,
  "pageCount": 59,
  "prevPage": 45,
  "nextPage": 47,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a pharmacokinetic line chart to demonstrate rapid absorption and a bulleted list to summarize clinical efficacy in GAD and panic models.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a7b5-7720-904b-d55cb9d2acd2/46",
  "deckHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2",
  "deckJsonHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2.json",
  "deckAnchorHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2#slide-46",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.41,
        "x": 0.06,
        "y": 0.24
      },
      "kind": "chart",
      "text": "Pharmacokinetic profile showing blood concentration over time for different doses",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89e69ce7-71d8-4267-a563-27e90d77914b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.48,
        "x": 0.48,
        "y": 0.21
      },
      "kind": "list",
      "text": "SAD shares many characteristics with General Anxiety Disorder (GAD), including a common neural basis in amygdala hyperactivation expressed as excessive or unrealistic anxiety. BNC210 clinically demonstrated its potential for reducing anxiety in acute treatment of GAD patients and following panic induction in healthy volunteers. Observed acute anxiolytic efficacy of BNC210 similar to lorazepam without sedating properties or addiction liability. Our studies also provide clear demonstration of efficacy using biomarker data including EEG and fMRI",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92226cba-ffe4-4517-bde3-54c2bc2ab9ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.08,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "EEG = Electroencephalogram; fMRI = Functional magnetic resonance imaging",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "017b9f48-f71f-4964-9a33-62c3e0d105f1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "BNC210's Unique Profile is Well-Positioned for Acute Treatment of SAD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e780bd2f-9997-4ca2-b6c1-dc21ffbe8445",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.48,
        "y": 0.16
      },
      "kind": "title",
      "text": "Proof of Concept in GAD and Panic Attack Model",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3dcc9c52-83bc-4f0b-88e0-1cceda82881a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.43,
        "x": 0.04,
        "y": 0.16
      },
      "kind": "title",
      "text": "Rapid Onset of Action with BNC210 Formulation",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bdec3a2-91df-4db3-aa22-bcaafe981e7d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 46,
      "from": 45,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "1e1d462c-8d62-43d6-9618-b535d192cafa",
      "evidence": "The deck presents BNC210 as a solution with a large market opportunity and potential for growth.",
      "position": 1,
      "objective": "Position BNC210 as a solution with a large market opportunity",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}